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Methyl-deficient (MD) diets cause liver
cancer in rodents (1). In addition, physio-
logical methyl insufﬁciency has been associ-
ated with increased risk of cancer and other
diseases such as pancreatic damage, athero-
sclerosis, birth defects, and neurological
disturbances, both in humans and in exper-
imental animals (2). Abnormal biological
methylation appears to be implicated in the
development of such diseases, and the chief
physiological methyl donor S-adenosylme-
thionine (SAM) appears to be a key inter-
mediate involved in these pathologies. One
major effect of the chronic feeding of MD
diets is the alteration of DNA methylation
(3). This reaction is catalyzed by the
enzyme DNA methyltransferase (MTase),
which transfers methyl groups from SAM
to the C5 position of cytosine residue in
DNA (4). Alterations in MTase activity are
seen in both the preneoplastic and the neo-
plastic livers of MD rats (3). Abnormalities
in DNA methylation are associated with
many diseases (5) and appear to be impli-
cated in inappropriate gene expression (6).
Several toxic metals, including Cd, are
known to produce toxic effects resembling
those seen with physiological methyl insufﬁ-
ciency (7,8). Cd exerts a synergistic effect
with the DNA-hypomethylating agent aza-
cytidine in the induction of metallothionein
in liver cells (9). Cd also reacts with the cys-
teine and histidine residues in proteins
(10,11). DNA MTase is a Zn finger–con-
taining protein that possesses both a cysteine
residue in the active center and Cys2/His2
Zn finger motifs in the N-terminal region
(4) and thus provides a reasonable target for
mediating the adverse effects of Cd in mam-
malian cells. We studied the inhibitory
effects of Cd on DNA MTase in the livers of
rats chronically fed a normal methyl-suffi-
cient (MS) diet and the corresponding car-
cinogenic MD diet, both with and without a
brief pretreatment of the animals with the
carcinogen aﬂatoxin B1 (AFB1).
Materials and Methods
The dietary regimes and the design of AFB1
dosing have been described previously (12).
At 5 weeks of age, the rats were randomly
assigned to receive either AFB1 (25
µg/rat/day, 5 days/week) or control dimethyl-
sulfoxide (100 µL/rat/day). After 3 weeks of
dosing (8 weeks of age), the rats were either
maintained on the MS diet or placed on the
MD diet for 7 or 24 weeks. Four treatment/
diet groups were thus examined: control/MS
(C/MS), control/MD (C/MD), AFB1/MS,
and AFB1/MD. Unless otherwise speciﬁed all
chemicals were supplied by Sigma-Aldrich
(St. Louis, MO, USA). The nuclear extracts
were isolated from the rat livers either at 7 or
at 24 weeks of the different dietary regimes
(13), and DNA MTase activity was deter-
mined in the nuclear extracts as described pre-
viously (14). Unless otherwise indicated, the
reaction mixture contained 1–2 µg hepatic
DNA, 1 µL (0.55 µCi) [methyl-3H]SAM
(Perkin-Elmer Life Sciences, Inc., Boston,
MA, USA) (specific activity, 13 Ci/mmol),
10 µL nuclear extract MTase (containing up
to 50 µg of protein), and the corresponding
concentrations of Zn or Cd acetate (Alfa
Aesar, Ward Hill, MA, USA) in 20 µL of
standard buffer solution (20 mM Tris–HCl
buffer, pH 7.5; 1 mM EDTA, 0.2 mM
dithiothreitol; and protease inhibitors: 0.1
mM phenylmethylsulfonyl ﬂuoride, 1 µg/mL
leupeptin, and 10 µg/mL each of TLCK,
TPCK, and E-64). The enzyme activity was
expressed as counts per minute (cpm) of
radioactivity incorporated per milligram of
protein from [methyl-3H]SAM into DNA
during the incubation of the reaction mixture
at 37°C for 1 hr under the above conditions.
In one study, the effects of Cd and Zn on
prokaryotic methylase Sss I (New England
Biolabs, Beverly, MA, USA) activity were
examined (14).
Results
We compared the effects of Cd and Zn on
DNA methylation by examining homolo-
gous methylation of hepatic DNA by
hepatic MTase in nuclear extracts isolated
from the livers of rats treated with AFB1
and subsequently fed the MS and MD diets
for 7 and 24 weeks. Figure 1 shows the reac-
tion velocities of the DNA methylation in
the four treatment groups after 7 experi-
mental weeks as a function of the log of
metal concentration in the MTase assay.
The increase of metal concentration from 1
to 500 µM causes a marked inhibition of
hepatic DNA methylation regardless of
whether the extracts had been obtained
from the MS or the MD livers or whether
the animals had been pretreated with AFB1.
With either the MS or MD dietary
groups, the inhibition by Zn of hepatic DNA
methylation displays simple kinetics (Figure
1); accordingly, the graph of an inverse of the
reaction velocity versus Zn concentration
shows no deviation from linearity (Figure 2).
These results suggest that only one type of
Zn-binding site is implicated in inhibiting
DNA methylation.
With the MS groups, the inhibition by
Cd of hepatic DNA methylation is also
described by a simple kinetic curve (Figure 1),
and the plot of an inverse of the reaction
velocity as a function of Cd concentration is
linear (Figure 2). However, in each group, the
concentration of Cd causing a 50% inhibition
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of hepatic DNA methylation is 3- to 4-fold
lower than the corresponding concentration
of Zn (Figure 3). With the MD groups, the
kinetics of Cd inhibition of hepatic DNA
methylation are described by S-shape curves
(Figure 1), and the dependence of the recipro-
cal of the reaction velocity on Cd concentra-
tion show marked deviations from linearity
(Figure 2). These results suggest that the
impairment of DNA methylation by Cd can
involve more than one process. With the MD
groups, the concentrations of Cd causing a
50% inhibition of hepatic DNA methylation
are also much lower than the corresponding
concentrations of Zn (Figure 3).
The experiments described in Figures
1–3 were repeated with the same four
experimental groups at 24 weeks. The
kinetics of Cd and Zn inhibition of DNA
methylation in the 24-week hepatic nuclear
extracts were similar to those observed in
the corresponding extracts isolated at 7
weeks. Similarly, both Cd and Zn inhibit
the activity of the bacterial Sss I MTase
(Figure 4).
Discussion
The present results on the inhibition by Cd
and Zn of mammalian and bacterial MTases
suggest a possible mechanism to explain the
carcinogenicity of Cd. The kinetics of inhi-
bition by Cd and Zn of the methylation of
hepatic DNA from MS rats is qualitatively
similar. This inhibition may be caused by
binding of these metals to the cysteine
residue in the active center of MTase (4).
Both Cd and Zn also inhibit the activity of
prokaryotic Sss I MTase (Figure 4), which,
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Figure 1. The effect of MD diet on the kinetics of the inhibition by Cd and Zn of hepatic DNA methylation by
hepatic DNA MTase. In each group, 100% activity corresponds to the activity obtained without the presence
of a metal in MTase assay.
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Figure 2. The inverse of the velocity of hepatic DNA methylation by hepatic DNA MTase as a function of
metal concentration in MTase assay. The equation for the reaction velocity (v) in the presence of sub-
strate S and noncompetitive inhibitor I may be rearranged (14) as 1/v = [(1 + Ks/S)/Vm] × (1 + I/Ki), which
gives the linear dependence of an inverse of the velocity on the inhibitor concentration at the constant
substrate concentration.
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Figure 3. The effect of MD diet on Cd and Zn con-
centrations that caused 50% activity inhibition (IC50)
of hepatic DNA methylation by hepatic DNA MTase.
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Figure 4. The inhibition by Cd and Zn of DNA
methylation by Sss I MTase. The MTase assays
contained 3 U of Sss I MTase and 1.5 µg of calf
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like mammalian MTase, possesses a cysteine
residue in its active center (4).
The kinetics of inhibition by Cd and by
Zn of the methylation by homologous
MTase of hepatic DNA from MD rats,
however, were quite dissimilar: such inhibi-
tion by Zn was similar to that seen with the
MS extracts; the inhibition by Cd was not.
This difference may be ascribed to the dif-
ferent effects of Cd and Zn on the binding
of the Zn finger domain of mammalian
MTase to DNA. Cd may prevent the bind-
ing of the MTase Zn ﬁnger to DNA. Such
effects by Cd have been shown with other
Zn finger proteins (11,15). The Zn finger
domain in mammalian MTase is not essen-
tial for catalytic activity, but its absence
alters site specificity and increases the
de novo methylation activity of the enzyme
(16). A weakening by Cd of the binding of
the Zn finger MTase domain to DNA
would thus be expected to be especially
manifested when hypomethylated DNA is
used as a substrate. Such was the case in
these studies (13). In conclusion, the inhibi-
tion by Cd of mammalian MTase provides a
biochemical mechanism by which the toxic-
ity of this metal may be linked to that of
other agents altering DNA methylation.
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